<DOC>
	<DOCNO>NCT01614509</DOCNO>
	<brief_summary>This study compare efficacy intravitreal bevacizumab monotherapy combine therapy posterior subtenon 's triamcinolone acetonide intravitreal bevacizumab treatment macular edema associate branch retinal vein occlusion .</brief_summary>
	<brief_title>Combined Therapy Posterior Subtenon Triamcinolone Acetonide Intravitreal Bevacizumab Macular Edema Secondary Branch Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Proxymetacaine</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . The participant must macular edema associate branch retinal vein occlusion . 2 . The participant retinal photograph , optical coherence tomography ( OCT ) angiography sufficient quality , allow assessment macular area accord standard clinical practice . 3 . The participant must willing able comply protocol . 1 . The participant BRVO ocular vascular disease central retinal vein occlusion , hypertensive retinopathy , etc . 2 . The participant additional ocular disease irreversibly compromise could likely compromise visual acuity study eye include amblyopia , anterior ischemic optic neuropathy , clinically significant diabetic macular edema , severe non proliferative diabetic retinopathy , proliferative diabetic retinopathy . 3 . The participant history treatment BRVO study eye focal laser photocoagulation , intravitreal triamcinolone acetonide injection intravitreal Bevacizumab injection 4 . The participant history intraocular surgery ( include lens replacement surgery ) . 5 . The participant history ocular trauma , current ocular periocular infection ( include history ocular herpes zoster simplex ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>branch retinal vein occlusion</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>triamcinolone acetonide</keyword>
</DOC>